MedTech Strategies
delivering insights to optimize product development and market success
We combine deep industry expertise with advanced analytical methods to help clients navigate complex market landscapes, optimize product performance, and achieve sustainable growth.
Ideation & Product
Concept Testing
Early-stage product development, generating and refining ideas, understanding market needs
Market Feasibility &
Validation
Evaluating market potential, risks, and readiness for launch
Regulatory & Market Access
Strategies
Navigating compliance, market entry, expansion, and reimbursement strategies
Pricing & Competitive
Positioning
Defining pricing models and ensuring market competitiveness
Marketing & GTM
Strategies
Message testing, brand assessment and market prioritization
Post-launch & Lifecycle
Management
Ongoing product support, adaptation to market changes, and ensuring long-term viability and sustainability
Where we engage with the market
TriMar Strategies regularly participates in diagnostics, MedTech, laboratory medicine, and healthcare strategy meetings. These forums help us stay close to emerging technologies, commercial priorities, market access challenges, and customer needs.
ADLM 2026 | Anaheim, USA | July 27–30, 2026
Organizing committee / panel moderation at the International Market Briefing: Expanding Access in Diagnostics: The Evolving Role of Testing Across Settings
Dr. Mark Whitten is moderating a panel on how diagnostic testing is increasingly delivered across multiple care settings, from the core lab to near-patient and home-based models, creating new opportunities to expand access and reach patients more effectively.
